Page last updated: 2024-10-30

metformin and Adamantiades-Behcet Disease

metformin has been researched along with Adamantiades-Behcet Disease in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Metformin treatment relieves the clinical symptoms, reduces the inflammatory reaction indexes and regulates the Treg/Th17 axis in patients with BD, suggesting the potential of metformin as a candidate medicine for treatment of BD."1.51[Efficacy and safety of metformin for Behcet's disease and its effect on Treg/Th17 balance: a single-blinded, before-after study]. ( Chenhong, L; Dan, L; Jianfei, C; Jianlong, G; Yan, S; Yong, C, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yong, C1
Dan, L1
Chenhong, L1
Yan, S1
Jianfei, C1
Jianlong, G1

Other Studies

1 other study available for metformin and Adamantiades-Behcet Disease

ArticleYear
[Efficacy and safety of metformin for Behcet's disease and its effect on Treg/Th17 balance: a single-blinded, before-after study].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2019, 02-28, Volume: 39, Issue:2

    Topics: Behcet Syndrome; Controlled Before-After Studies; Forkhead Transcription Factors; Humans; Immunosupp

2019